FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Parasitology research2010; 107(6); 1495-1498; doi: 10.1007/s00436-010-2025-5

Critical tests evaluating efficacy of moxidectin against small strongyles in horses from a herd for which reduced activity had been found in field tests in Central Kentucky.

Abstract: Critical tests were performed in 2009 and 2010 in four 2-year-old horses naturally infected with internal parasites. The horses were from a herd (Farm MC) where reduced activity of ivermectin and moxidectin on small strongyles was demonstrated previously from EPG (eggs/gram of feces) data in field tests. Also, in critical tests in horses from the same herd, ivermectin was less effective on immature small strongyles in the lumen of the large intestine than when the drug was first marketed. The main interest in the present critical tests was to determine the efficacy of moxidectin (400 μg/kg) on small strongyles. This was done to try and find indications of why there has been a return of strongyle EPG counts sooner after treatment in field tests than when moxidectin was first commercially available. Removal of adult small strongyles for the four treated horses was >99% to 100%. Efficacy on immature (L(4)) small strongyles was 82%, 96%, 98%, and >99% for the individual horses. Identification of small strongyles recovered from two of the horses revealed that three genera and 11 species were present. Specimens of Cylicocyclus ashworthi are reported for the first time in horses in Kentucky although eggs of this species have been identified. Moxidectin, in the present study, was excellent on removing adult small strongyles but was less effective on immatures (L(4)) in the intestinal contents. The question as to why moxidectin efficacy on small strongyles has declined in field tests may have been answered at least to a certain extent. It seems that a significant factor is "quick development" of a few remaining immatures in the gut lumen of horses. Also, possible activity may have decreased on encysted stages in the large intestinal lining. In any event, after treatment of some horses with moxidectin, the life cycle of small strongyles is shorter now than at the onset of usage of this compound.
Get Full Text
Publication Date: 2010-08-17 PubMed ID: 20714749DOI: 10.1007/s00436-010-2025-5Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigated the effectiveness of the drug moxidectin in treating internal parasites in horses, with focus on small strongyles. Interesting outcomes suggests while moxidectin efficiently gets rid of adult small strongyles, it’s less effective on the immature versions of the parasite, possibly leading to early recurrence of infection.

Background

  • The study took place over 2009 and 2010 on four 2-year-old horses naturally infected with internal parasites. The horses were part of a herd, identified as Farm MC, in which earlier studies had shown reduced effectiveness of anti-parasitic drugs ivermectin and moxidectin against small strongyles.

Objectives

  • The aim of this research was to assess the efficacy of moxidectin on small strongyles in horses from the same herd where the reduced activity of the medicine had been previously discovered.
  • Another goal was to understand why there’s a quicker return of strongyle EPG (eggs per gram of feces) counts following treatment in field tests than when moxidectin was initially released into the market.

Key Findings

  • The study revealed that moxidectin was successful in eliminating adult small strongyles in the tested horses, featuring a removal rate ranging between 99% and 100%.
  • However, for immature small strongyles, the efficacy was less ranging between 82% and 99% across the different individual horses subjected to the tests.
  • The study resulted in the identification of three genera and 11 species of small strongyles from two of the horses. This included the identification of Cylicocyclus ashworthi in horses in Kentucky for the first time.

Conclusion and Implications

  • The study findings hint at why the effectiveness of moxidectin against small strongyles may have decreased over time. A significant influence seems to be the ‘quick development’ of a few residual immature strongyles inside the gut of horses. This suggests that post treatment, the lifecycle of small strongyles is shorter now than in the onset of usage of the drug.
  • Additionally, the research suggests that the efficacy of moxidectin might have also reduced on encysted stages in the large intestine lining. The implication being that more research is necessary to fully understand the decreased effectiveness of the drug and develop solutions to this issue.

Cite This Article

APA
Lyons ET, Tolliver SC, Kuzmina TA, Collins SS. (2010). Critical tests evaluating efficacy of moxidectin against small strongyles in horses from a herd for which reduced activity had been found in field tests in Central Kentucky. Parasitol Res, 107(6), 1495-1498. https://doi.org/10.1007/s00436-010-2025-5

Publication

Parasitology research
ISSN: 1432-1955
NlmUniqueID: 8703571
Country: Germany
Language: English
Volume: 107
Issue: 6
Pages: 1495-1498

Researcher Affiliations

Lyons, Eugene T
  • Department of Veterinary Science, Gluck Equine Research Center, University of Kentucky, Lexington, KY 40546-0099, USA. elyons1@uky.edu
Tolliver, Sharon C
    Kuzmina, Tetiana A
      Collins, Sandra S

        MeSH Terms

        • Animals
        • Anthelmintics / administration & dosage
        • Feces / parasitology
        • Horse Diseases / drug therapy
        • Horses
        • Kentucky
        • Macrolides / administration & dosage
        • Parasite Egg Count
        • Strongylida / classification
        • Strongylida / isolation & purification
        • Strongylida Infections / drug therapy
        • Strongylida Infections / veterinary
        • Strongyloidea / drug effects
        • Treatment Outcome

        References

        This article includes 13 references
        1. Scholl PJ, Chapman MR, French DD, Klei TR. Efficacy of moxidectin 2% oral gel against second- and third-instar Gasterophilus intestinalis De Geer.. J Parasitol 1998 Jun;84(3):656-7.
          pubmed: 9645883
        2. DRUDGE JH, SZANTO J, WYANT ZN, ELAM G. CRITICAL TESTS OF THIABENDAZOLE AS AN ANTHELMINTIC IN THE HORSE.. Am J Vet Res 1963 Nov;24:1217-22.
          pubmed: 14081458
        3. Drudge JH, Lyons ET. Methods in the evaluation of antiparasitic drugs in the horse.. Am J Vet Res 1977 Oct;38(10):1581-6.
          pubmed: 337859
        4. Klei TR, Rehbein S, Visser M, Langholff WK, Chapman MR, French DD, Hanson P. Re-evaluation of ivermectin efficacy against equine gastrointestinal parasites.. Vet Parasitol 2001 Jul 27;98(4):315-20.
          pubmed: 11423189doi: 10.1016/s0304-4017(01)00436-8google scholar: lookup
        5. Cleale RM, Edmonds JD, Paul AJ, Reinemeyer CR, Chapman MR, Clem R, Meccoli RA, Tolliver SC, Amodie DM. A multicenter evaluation of the effectiveness of Quest Gel (2% moxidectin) against parasites infecting equids.. Vet Parasitol 2006 Apr 15;137(1-2):119-29.
          pubmed: 16414194doi: 10.1016/j.vetpar.2005.11.029google scholar: lookup
        6. Lyons ET, Tolliver SC, Collins SS. Probable reason why small strongyle EPG counts are returning "early" after ivermectin treatment of horses on a farm in Central Kentucky.. Parasitol Res 2009 Feb;104(3):569-74.
          pubmed: 18931857doi: 10.1007/s00436-008-1231-xgoogle scholar: lookup
        7. von Samson-Himmelstjerna G, Fritzen B, Demeler J, Schürmann S, Rohn K, Schnieder T, Epe C. Cases of reduced cyathostomin egg-reappearance period and failure of Parascaris equorum egg count reduction following ivermectin treatment as well as survey on pyrantel efficacy on German horse farms.. Vet Parasitol 2007 Mar 15;144(1-2):74-80.
          pubmed: 17112667doi: 10.1016/j.vetpar.2006.09.036google scholar: lookup
        8. Edward CL, Hoffmann AA. Ivermectin resistance in a horse in Australia.. Vet Rec 2008 Jan 12;162(2):56-7.
          pubmed: 18192659doi: 10.1136/vr.162.2.56google scholar: lookup
        9. Boersema JH, Eysker M, Maas J, van der Aar WM. Comparison of the reappearance of strongyle eggs on foals, yearlings and adult horses after treatment with ivermectin or pyrantel.. Vet Q 1996 Mar;18(1):7-9.
          pubmed: 8833604doi: 10.1080/01652176.1996.9694602google scholar: lookup
        10. Molento MB, Antunes J, Bentes RN, Coles GC. Anthelmintic resistant nematodes in Brazilian horses.. Vet Rec 2008 Mar 22;162(12):384-5.
          pubmed: 18359933doi: 10.1136/vr.162.12.384google scholar: lookup
        11. Lyons ET, Tolliver SC, Ionita M, Lewellen A, Collins SS. Field studies indicating reduced activity of ivermectin on small strongyles in horses on a farm in Central Kentucky.. Parasitol Res 2008 Jun;103(1):209-15.
          pubmed: 18389281doi: 10.1007/s00436-008-0959-7google scholar: lookup
        12. Ionita M, Howe DK, Lyons ET, Tolliver SC, Kaplan RM, Mitrea IL, Yeargan M. Use of a reverse line blot assay to survey small strongyle (Strongylida: Cyathostominae) populations in horses before and after treatment with ivermectin.. Vet Parasitol 2010 Mar 25;168(3-4):332-7.
          pubmed: 20045254doi: 10.1016/j.vetpar.2009.11.021google scholar: lookup
        13. Little D, Flowers JR, Hammerberg BH, Gardner SY. Management of drug-resistant cyathostominosis on a breeding farm in central North Carolina.. Equine Vet J 2003 May;35(3):246-51.
          pubmed: 12755426doi: 10.2746/042516403776148264google scholar: lookup

        Citations

        This article has been cited 12 times.
        1. Bull KE, Allen KJ, Hodgkinson JE, Peachey LE. The first report of macrocyclic lactone resistant cyathostomins in the UK. Int J Parasitol Drugs Drug Resist 2023 Apr;21:125-130.
          doi: 10.1016/j.ijpddr.2023.03.001pubmed: 36940551google scholar: lookup
        2. Scala A, Tamponi C, Sanna G, Predieri G, Dessì G, Sedda G, Buono F, Cappai MG, Veneziano V, Varcasia A. Gastrointestinal Strongyles Egg Excretion in Relation to Age, Gender, and Management of Horses in Italy. Animals (Basel) 2020 Dec 3;10(12).
          doi: 10.3390/ani10122283pubmed: 33287298google scholar: lookup
        3. Bellaw JL, Nielsen MK. Meta-analysis of cyathostomin species-specific prevalence and relative abundance in domestic horses from 1975-2020: emphasis on geographical region and specimen collection method. Parasit Vectors 2020 Oct 12;13(1):509.
          doi: 10.1186/s13071-020-04396-5pubmed: 33046130google scholar: lookup
        4. Nielsen MK, Banahan M, Kaplan RM. Importation of macrocyclic lactone resistant cyathostomins on a US thoroughbred farm. Int J Parasitol Drugs Drug Resist 2020 Dec;14:99-104.
          doi: 10.1016/j.ijpddr.2020.09.004pubmed: 33022574google scholar: lookup
        5. Leathwick DM, Sauermann CW, Nielsen MK. Managing anthelmintic resistance in cyathostomin parasites: Investigating the benefits of refugia-based strategies. Int J Parasitol Drugs Drug Resist 2019 Aug;10:118-124.
          doi: 10.1016/j.ijpddr.2019.08.008pubmed: 31491731google scholar: lookup
        6. Hellman LT, Akula S, Thorpe M, Fu Z. Tracing the Origins of IgE, Mast Cells, and Allergies by Studies of Wild Animals. Front Immunol 2017;8:1749.
          doi: 10.3389/fimmu.2017.01749pubmed: 29312297google scholar: lookup
        7. Bredtmann CM, Krücken J, Murugaiyan J, Kuzmina T, von Samson-Himmelstjerna G. Nematode Species Identification-Current Status, Challenges and Future Perspectives for Cyathostomins. Front Cell Infect Microbiol 2017;7:283.
          doi: 10.3389/fcimb.2017.00283pubmed: 28702376google scholar: lookup
        8. Fischer JK, Hinney B, Denwood MJ, Traversa D, von Samson-Himmelstjerna G, Clausen PH. Efficacy of selected anthelmintic drugs against cyathostomins in horses in the federal state of Brandenburg, Germany. Parasitol Res 2015 Dec;114(12):4441-50.
          doi: 10.1007/s00436-015-4685-7pubmed: 26337266google scholar: lookup
        9. Matthews JB. Anthelmintic resistance in equine nematodes. Int J Parasitol Drugs Drug Resist 2014 Dec;4(3):310-5.
          doi: 10.1016/j.ijpddr.2014.10.003pubmed: 25516842google scholar: lookup
        10. Kuzmina TA, Tolliver SC, Lyons ET. Three recently recognized species of cyathostomes (Nematoda: Strongylidae) in equids in Kentucky. Parasitol Res 2011 May;108(5):1179-84.
          doi: 10.1007/s00436-010-2160-zpubmed: 21107866google scholar: lookup
        11. Elghryani N, Lawlor A, McOwan T, de Waal T. Unravelling the Effectiveness of Anthelmintic Treatments on Equine Strongyles on Irish Farms. Animals (Basel) 2024 Jul 2;14(13).
          doi: 10.3390/ani14131958pubmed: 38998069google scholar: lookup
        12. Nielsen MK. Anthelmintic resistance in equine nematodes: Current status and emerging trends. Int J Parasitol Drugs Drug Resist 2022 Dec;20:76-88.
          doi: 10.1016/j.ijpddr.2022.10.005pubmed: 36342004google scholar: lookup
        Subscribe to our newsletter
        Join 99,780 horse owners like you who receive our email updates on horse health and nutrition.